barriers to glp-1 medication prescription ➡️ Authors of a report in @JAADjournals investigated potential associations between telogen effluvium (TE) and treatment for weight loss. Patients with a BMI of ≥30 without diabetes were included in the GLP-1s are great, but researchers

The cost difference is meaningful for patients on a budget, and semaglutide remains the more affordable option

Keep in mind your individual needs may be lower or higher to hit your goals and to be appropriate for you

The CMS said it will release additional details on participation in early 2026

For example, the report said the patient has insurance coverage for Wegovy and meets the eligibility requirements for their plan's prior authorization, such as having a certain body mass index and other health conditions like diabetes and heart disease

This week, Nestl showed how seriously its taking the Ozempic trend, with its Health Science unit launching a dedicated website to provide nutritional support for people on weight loss programmes, including GLP-1 medication users

GLP-1RAs as novel and promising drugs for T2DM, they could stimulate insulin secretion in a glucose-dependent manner, protect cell function, and suppress glucagon secretion (Lindamood and Taylor, 2015